Clinical trials
Phase 2/3 Leukemia, Myeloid, Acute trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Gruppo Italiano Trapianto di Midollo Osseo | 1 |
| Moleculin Biotech, Inc. | 1 |
| Taiho Oncology, Inc. | 1 |
| University Hospital, Udine, Italy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 7 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Leukemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Myelodysplastic Syndromes | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Congenital Abnormalities | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.